PMID: 3756818Nov 1, 1986Paper

An excess of uterine sarcomas after pelvic irradiation

Cancer
R F MeredithJ G Boutselis

Abstract

The Ohio State University Registry recorded 1208 uterine corpus malignancies between 1940 and 1983. Thirty cases occurred in women with a history of pelvic irradiation. Eight patients had previously been irradiated for pelvic malignancy, four of whom presented with advanced stage sarcomas and died of their disease within 14 months. This represents an increase over the expected sarcoma prevalence which is less than 5%. In contrast, the majority of women (20 of 22) previously irradiated for benign conditions were diagnosed with endometrial adenocarcinoma. In 18, the adenocarcinoma was diagnosed as Stage I, and the prognosis was only slightly less favorable than for nonirradiated women. No significant effect of age at the time of irradiation was apparent. This study of women with a history of pelvic irradiation who later developed uterine cancer demonstrates a tendency for patients previously irradiated for pelvic malignancy to present with advanced stage, extremely aggressive uterine tumors compared to those previously irradiated for benign conditions.

References

Feb 1, 1978·The Surgical Clinics of North America·J G Boutselis
Aug 1, 1978·Gynecologic Oncology·K Cześnin, Z Wronkowski
Jan 1, 1976·British Journal of Obstetrics and Gynaecology·R F Mould, A Barrett
Jan 1, 1975·Radiology·R BelgradP Rubin
Jul 1, 1974·American Journal of Obstetrics and Gynecology·P E Fehr, K A Prem
Feb 15, 1973·American Journal of Obstetrics and Gynecology·R F Morton, U Villasanta
Apr 15, 1970·American Journal of Obstetrics and Gynecology·A N Arneson, H F Schellhas
May 1, 1968·The British Journal of Radiology·R Doll, P G Smith
Jul 1, 1969·The British Journal of Radiology·D Brinkley, J L Haybittle
Jul 1, 1984·Gynecologic Oncology·M J MarcheseH C Frick
Jan 1, 1980·International Journal of Gynaecology and Obstetrics : the Official Organ of the International Federation of Gynaecology and Obstetrics·V NikkanenM Grönroos
Feb 1, 1982·International Journal of Radiation Oncology, Biology, Physics·J Y LeeB B Fineberg
Sep 1, 1956·American Journal of Obstetrics and Gynecology·J P PALMER, D W SPRATT
Jan 1, 1946·American Journal of Obstetrics and Gynecology·J A CORSCADENS B GUSBERG

❮ Previous
Next ❯

Citations

May 8, 2008·Archives of Gynecology and Obstetrics·Fabrice LeungCatherine Lassabe
Jun 12, 2002·Current Treatment Options in Oncology·M L Hensley
May 1, 1993·European Journal of Obstetrics, Gynecology, and Reproductive Biology·B MorrelJ A Wijnen
Feb 1, 1989·Gynecologic Oncology·E S PodczaskiR Mortel
Feb 18, 2004·International Journal of Radiation Oncology, Biology, Physics·Michael CallisterPatricia J Eifel
Apr 29, 1999·International Journal of Radiation Oncology, Biology, Physics·F FerrerN Daly-Schveitzer
Nov 26, 1999·International Journal of Radiation Oncology, Biology, Physics·E M MurrayD A Taylor
Apr 4, 2001·International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society·L H WeiC Y Hsieh
Jul 30, 2002·International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society·P InthasornC Dalrymple
May 10, 2013·The New England Journal of Medicine·Richard T PensonEsther Oliva
Jul 1, 2006·International Journal of Gynecological Pathology : Official Journal of the International Society of Gynecological Pathologists·Jeffrey D SeidmanCharles R Boice
Sep 24, 2009·Obstetrical & Gynecological Survey·Leigh A Cantrell, Linda Van Le
Feb 23, 2010·International Journal of Gynecological Pathology : Official Journal of the International Society of Gynecological Pathologists·Oluwole FadareVinita Parkash
Jun 24, 2003·AJR. American Journal of Roentgenology·Aylin TekesDavid A Bluemke
May 2, 2003·Diagnostic Cytopathology·Mary B CaseyDiva R Salomão
Aug 3, 2010·Cancer radiothérapie : journal de la Société française de radiothérapie oncologique·C ChampetierUNKNOWN Cercle des Oncologues Radiothérapeutes du Sud
Apr 28, 2009·Gynécologie, obstétrique & fertilité·F LeungD Riethmuller
Oct 19, 2011·Obstetrics and Gynecology International·Rani Kanthan, Jenna-Lynn Senger
Jan 1, 1991·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·K S OláhK K Chan
Oct 1, 1989·Gynecologic Oncology·P A De FuscoS S Cha
Nov 15, 2006·Clinical Oncology : a Journal of the Royal College of Radiologists·M ChandiramaniM Decatris
Aug 12, 1998·Gynecologic Oncology·R R NordalJ M Nesland
Jun 19, 2013·Gynecologic Oncology·Gregory Sutton
Oct 10, 2014·Advances in Anatomic Pathology·Christopher M J Conklin, Teri A Longacre
Oct 15, 2018·Oncology Research and Treatment·Falk C Thiel, Sonja Halmen
Feb 25, 2010·Advances in Anatomic Pathology·Ivy Chew, Esther Oliva
Feb 6, 2018·Journal of Gynecologic Oncology·Koji MatsuoLynda D Roman
Mar 2, 2017·Abdominal Radiology·Matthias BarralPhilippe Soyer
Dec 1, 1990·Otolaryngology--head and Neck Surgery : Official Journal of American Academy of Otolaryngology-Head and Neck Surgery·A K Lalwani, M J Kaplan
Sep 11, 2020·International Journal of Surgical Pathology·Michela LibertiniRobin L Jones
Mar 31, 2018·South Asian Journal of Cancer·Anne George CherianAbraham Peedicayil
Apr 4, 2021·Diagnostics·Iolia AkaevSiavash Rahimi

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.